Meeting
2014 ASCO Annual Meeting
Activity of chemotherapy in a series of patients with locally advanced or metastatic pleomorphic rhabdomyosarcoma: A retrospective analysis.
Authors
Michela Libertini
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Michela Libertini , Nadia Hindi , Salvatore Provenzano , Rossella Bertulli , Roberta Sanfilippo , Silvia Stacchiotti , Elena Palassini , Elena Fumagalli , Giacomo G. Baldi , Bruno Vincenzi , Angelo Paolo Dei Tos , Alessandro Gronchi , Paolo Giovanni Casali
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 10592)
DOI
10.1200/jco.2014.32.15_suppl.10592
Abstract #
10592
Poster Bd #
299
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Personalized therapy for head and neck squamous carcinoma (HNSCC) utilizing tissue proteomics profiling.
First Author: Sheeno P. Thyparambil
Poster
2022 ASCO Annual Meeting
Risk-adapted local therapy and intensive chemotherapy in patients with high-risk rhabdomyosarcoma.
First Author: Michael W. Bishop
Poster
2020 Gastrointestinal Cancers Symposium
A phase II trial of pembrolizumab in combination with cisplatin or carboplatin and etoposide in chemotherapy naive patients with metastatic or unresectable high-grade gastroenteropanncreatic or lung neuroendocrine carcinoma.
First Author: Robert A. Ramirez
Poster
2016 Gastrointestinal Cancers Symposium
A phase II study of biweekly gemcitabine at fixed dose rate infusion plus S1 as first-line chemotherapy in patients with locally advanced or metastatic pancreatic cancer.
First Author: Xj Xiang